Morgan Stanley reiterated its Equal-weight rating on Medtronic MDT. At the moment, Morgan Stanley does not have a price target placed on the company's stock. On Tuesday, Medtronic added 1.11% to its value to end the day at $39.01. Its shares lost all of yesterday's gains in today's pre-market trading, however, falling 1.18% to $38.55.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
